LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 78.60 | 27.76 | 571 | 7045 | 0.0810 | 0.4602 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 80.31 | 27.76 | 10 | 6976 | 0.0014 | -0.1202 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 80.31 | 27.76 | 609 | 6976 | 0.0873 | 0.4730 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 80.31 | 27.76 | 1 | 6976 | 0.0001 | -0.3409 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 80.31 | 27.76 | 544 | 6976 | 0.0780 | 0.4523 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 82.01 | 27.76 | 10 | 7000 | 0.0014 | -0.1201 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 82.01 | 27.76 | 600 | 7000 | 0.0857 | 0.4699 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 82.01 | 27.76 | 1 | 7000 | 0.0001 | -0.3407 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 82.01 | 27.76 | 508 | 7000 | 0.0726 | 0.4396 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 83.72 | 27.76 | 6 | 7055 | 0.0009 | -0.1745 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 83.72 | 27.76 | 599 | 7055 | 0.0849 | 0.4688 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 83.72 | 27.76 | 1 | 7055 | 0.0001 | -0.3403 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 83.72 | 27.76 | 490 | 7055 | 0.0694 | 0.4324 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 85.42 | 27.76 | 5 | 7025 | 0.0007 | -0.1932 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 85.42 | 27.76 | 588 | 7025 | 0.0837 | 0.4659 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 85.42 | 27.76 | 1 | 7025 | 0.0001 | -0.3405 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 85.42 | 27.76 | 468 | 7025 | 0.0666 | 0.4245 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 87.13 | 27.76 | 5 | 6987 | 0.0007 | -0.1934 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 87.13 | 27.76 | 589 | 6987 | 0.0843 | 0.4667 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 87.13 | 27.76 | 1 | 6987 | 0.0001 | -0.3408 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 87.13 | 27.76 | 459 | 6987 | 0.0657 | 0.4216 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 88.84 | 27.76 | 4 | 6965 | 0.0006 | -0.2158 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 88.84 | 27.76 | 587 | 6965 | 0.0843 | 0.4664 | MN20160318_Q01 | E13 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 88.84 | 27.76 | 1 | 6965 | 0.0001 | -0.3410 | MN20160318_Q01 | K20 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 88.84 | 27.76 | 450 | 6965 | 0.0646 | 0.4183 | MN20160318_Q01 | K20 |